Related Experiment Videos
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation
Maria E Bamberger1, Meera E Harris, Douglas R McDonald
1Alzheimer Research Laboratory, Program in Cell Biology and Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Summary
Researchers identified a receptor complex on microglia that binds to beta-amyloid (Abeta) fibrils, triggering inflammation in Alzheimer's disease. Blocking this complex may offer a new treatment strategy for Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Alzheimer's disease (AD) brains exhibit senile plaques with activated microglia, indicating local inflammatory responses.
- Microglial activation by beta-amyloid (Abeta) fibrils drives inflammatory pathways, contributing to AD pathogenesis.
Purpose of the Study:
- To identify the cell surface receptor complex mediating microglial binding to Abeta fibrils.
- To investigate how this binding activates intracellular signaling and leads to a proinflammatory response.
Main Methods:
- Utilized THP-1 monocytes and murine microglia models.
- Tested antagonists and peptide competitors for scavenger receptors, CD36, CD47, and alpha(6)beta(1)-integrin.
- Assessed inhibition of Abeta fibril adhesion, Tyr kinase signaling, interleukin-1beta production, and reactive oxygen species generation.
Main Results:
- Identified a receptor complex including CD36, CD47, and alpha(6)beta(1)-integrin for Abeta fibril binding.
- Inhibitors of this complex blocked monocyte adhesion to Abeta fibrils.
- Blocking the complex also inhibited Abeta-induced Tyr kinase signaling, IL-1beta production, and reactive oxygen species generation.
Conclusions:
- The identified receptor complex is crucial for microglial recognition and activation by Abeta fibrils in AD.
- These receptors are shared with other fibrillar proteins, suggesting a general mechanism for myeloid cell recognition.
- Targeting this receptor complex presents a potential therapeutic intervention point for Alzheimer's disease treatment.